Why the study?
The relationship between ocular vascular resistance parameters evaluated by laser speckle flowgraphy and systemic atherosclerosis, renal parameters, and cardiac function in ACS patients was unknown.
Is ocular resistivity index associated with systemic atherosclerosis, renal dysfunction, and cardiac dysfunction in patients with acute coronary syndrome?
Is ocular resistivity index associated with systemic atherosclerosis, renal dysfunction, and cardiac dysfunction in patients with acute coronary syndrome?
Ocular resistivity index measured by laser speckle flowgraphy may serve as a useful non-invasive marker for systemic arteriosclerosis, early renal dysfunction, and diastolic cardiac dysfunction in ACS patients.
Answers are grounded in this paper and cite their sources.
Ocular LSFG parameters may reflect systemic disease in ACS; hypothesis-generating and requires prospective validation before clinical use.
This study aimed to investigate the relationship between ocular vascular resistance parameters, evaluated by laser speckle flowgraphy (LSFG), and systemic atherosclerosis, renal parameters and cardiac function in acute coronary syndrome (ACS) patients. We evaluated 53 ACS patients between April 2019 and September 2020. LSFG measured the mean blur rate (MBR) and ocular blowout time (BOT) and resistivity index (RI). 110 consequent patients without a history of coronary artery disease who visited ophthalmology as a control group. Significant positive correlations were observed between ocular RI and systemic parameters in ACS patients, including intima-media thickness (r = 0.34, P = 0.015), brachial-ankle pulse-wave velocity (r = 0.41, P = 0.002), cystatin C (r = 0.32, P = 0.020), and E/e' (r = 0.34, P = 0.013). Ocular RI was significantly higher in the ACS group than in the control group in male in their 40 s (0.37 ± 0.02 vs. 0.29 ± 0.01, P < 0.001) and 50 s (0.36 ± 0.02 vs. 0.30 ± 0.01, P = 0.01). We found that the ocular RI was associated with systemic atherosclerosis, early renal dysfunction, and diastolic cardiac dysfunction in ACS patients, suggesting that it could be a useful non-invasive comprehensive arteriosclerotic marker.
No takes yet. Share an insight, caveat, or question.
Ebuchi et al. (2022) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: